Cargando…

Clinical Efficacy of Intravitreal Ranibizumab in Early and Mid-Idiopathic Choroidal Neovascularization

Background. To compare visual outcomes and spectral-domain optical coherence tomography results following intravitreal ranibizumab treatment for early and mid-idiopathic choroidal neovascularization (ICNV). Methods. This retrospective, case-controlled study examined 44 patients with ICNV in one eye...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fan, Chuanfeng, Ji, Qiang, Wang, Yu, Shu, Xiangwen, Xie, Juan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4020209/ https://www.ncbi.nlm.nih.gov/pubmed/24868452 http://dx.doi.org/10.1155/2014/382702

Ejemplares similares

Early Responses to Intravitreal Ranibizumab in Typical Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy
por: Matsumiya, Wataru, et al.
Publicado: (2011)

Single intravitreal ranibizumab for myopic choroidal neovascularization
por: Nor-Masniwati, Saidin, et al.
Publicado: (2011)

Idiopathic Choroidal Neovascularization: Intraocular Inflammatory Cytokines and the Effect of Intravitreal Ranibizumab Treatment
por: Yin, Houfa, et al.
Publicado: (2016)

Choroidal thickness after intravitreal ranibizumab injections for choroidal neovascularization
por: Ellabban, Abdallah A, et al.
Publicado: (2012)

Effect of Intravitreal Ranibizumab in the Treatment of Peripapillary Choroidal Neovascularisation
por: Hamoudi, Hassan, et al.
Publicado: (2011)

Intravitreal ranibizumab for the treatment of choroidal neovascularization secondary to ocular toxoplasmosis
por: Shah, Nikunj J, et al.
Publicado: (2011)

Intravitreal ranibizumab for the treatment of choroidal neovascularization secondary to ocular toxoplasmosis
por: Pandey, Neeraj, et al.
Publicado: (2013)

Intravitreal ranibizumab for treatment of choroidal neovascularization secondary to a bilateral choroidal osteoma
por: Zafar, Sidra, et al.
Publicado: (2016)

Successful management of peripapillary choroidal neovascular membrane secondary to idiopathic intracranial hypertension with intravitreal ranibizumab
por: Kumar, Nitin, et al.
Publicado: (2018)

Treatment of myopic choroidal neovascularization with intravitreal ranibizumab injections: the role of age
por: Karagiannis, Dimitrios, et al.
Publicado: (2017)

Visual Performance in Patients with Neovascular Age-Related Macular Degeneration Undergoing Treatment with Intravitreal Ranibizumab
por: Sabour-Pickett, Sarah, et al.
Publicado: (2013)

Intravitreal aflibercept for choroidal neovascularization secondary to angioid streaks in a non-responder to intravitreal ranibizumab
por: Makri, Olga E, et al.
Publicado: (2018)

Role of Intravitreal Antivascular Endothelial Growth Factor Injections for Choroidal Neovascularization due to Choroidal Osteoma
por: Mansour, Ahmad M., et al.
Publicado: (2014)

Long-Term Follow-Up of Intravitreal Ranibizumab for the Treatment of Choroidal Neovascularization due to Choroidal Osteoma
por: H.Y. Wu, Zenith, et al.
Publicado: (2012)

The Use of Intravitreal Ranibizumab for Choroidal Neovascularization Associated with Vogt-Koyanagi-Harada Syndrome
por: Kolomeyer, A. M., et al.
Publicado: (2011)

Treatment of Punctate Inner Choroidopathy with Choroidal Neovascularization Using Corticosteroid and Intravitreal Ranibizumab
por: Wu, Wei, et al.
Publicado: (2018)

Intravitreal Ranibizumab Injection as an Adjuvant in the Treatment of Neovascular Glaucoma Accompanied by Vitreous Hemorrhage after Diabetic Vitrectomy
por: Shen, Xi, et al.
Publicado: (2016)

Combination therapy of low-fluence photodynamic therapy and intravitreal ranibizumab for choroidal neovascular membrane in choroidal osteoma
por: Morris, Rodney J, et al.
Publicado: (2011)

Intravitreal Ranibizumab With Panretinal Photocoagulation Followed by Trabeculectomy Versus Visco-Trabeculotomy in Management of Neovascular Glaucoma
por: Elwehidy, Ahmed S., et al.
Publicado: (2019)

Electrophysiologic changes after intravitreal ranibizumab injection for the treatment of choroidal neovascular membrane (CNVM)
por: Bhurayanontachai, Patama, et al.
Publicado: (2011)

Long-term results of intravitreal ranibizumab for osteoma-related choroidal neovascularization in a child
por: Gupta, Aditi, et al.
Publicado: (2014)

Resolution of vitreomacular traction following intravitreal ranibizumab in cases of ocular toxoplasmosis with choroidal neovascularization
por: Petrou, Petros, et al.
Publicado: (2013)

Intravitreal ranibizumab in the treatment of choroidal neovascularization secondary to morning glory syndrome in a child
por: Özkaya, Abdullah, et al.
Publicado: (2016)

Comparisons of Efficacy of Intravitreal Aflibercept and Ranibizumab in Eyes with Diabetic Macular Edema
por: Shimizu, Norihiro, et al.
Publicado: (2017)

Comparison of the efficacy of intravitreal ranibizumab for choroidal neovascularization due to pathological myopia with and without a dome-shaped macula
por: Cai, Bincui, et al.
Publicado: (2017)

Choroidal Osteoma and Secondary Choroidal Neovascularization Treated with Ranibizumab
por: Sarıgül Sezenöz, Almila, et al.
Publicado: (2017)

Intravitreal ranibizumab for choroidal neovascularization in a patient with angioid streaks and multiple evanescent white dots
por: Pece, Alfredo, et al.
Publicado: (2016)

Multiple Intravitreal Ranibizumab Injections for Persistant Choroidal Neovascularization Associated with Presumed Ocular Histoplasmosis Syndrome
por: Yılmaz, Turgut, et al.
Publicado: (2017)

Intravitreal Aflibercept Outcomes in Patients with Persistent Macular Exudate Previously Treated with Bevacizumab and/or Ranibizumab for Neovascular Age-Related Macular Degeneration
por: Griffin, David R., et al.
Publicado: (2014)

The Application of OCTA in Assessment of Anti-VEGF Therapy for Idiopathic Choroidal Neovascularization
por: Chen, Qin, et al.
Publicado: (2016)

Intravitreal Bevacizumab as a Primary Treatment for Idiopathic Choroidal Neovascularization
por: Cheema, Rizwan A., et al.
Publicado: (2011)

Cytokine and Chemokine Profile Changes in Patients with Neovascular Age-Related Macular Degeneration After Intravitreal Ranibizumab Injection for Choroidal Neovascularization
por: Sun, Tingting, et al.
Publicado: (2021)

Comparative role of intravitreal ranibizumab versus bevacizumab in choroidal neovascular membrane in age-related macular degeneration
por: Biswas, Partha, et al.
Publicado: (2011)

Intravitreal Ranibizumab in the Treatment of Butterfly-Shaped Pattern Dystrophy Associated with Choroidal Neovascularization: A Case Report
por: Empeslidis, Theodoros, et al.
Publicado: (2012)

Peripapillary choroidal thickness after intravitreal ranibizumab injections in eyes with neovascular age-related macular degeneration
por: Yun, Cheolmin, et al.
Publicado: (2016)

EFFICACY AND SAFETY OF RANIBIZUMAB FOR THE TREATMENT OF CHOROIDAL NEOVASCULARIZATION DUE TO UNCOMMON CAUSE: Twelve-Month Results of the MINERVA Study
por: Lai, Timothy Y. Y., et al.
Publicado: (2018)

Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMD
por: Avery, Robert L, et al.
Publicado: (2014)

Treatment patterns of ranibizumab intravitreal injection and dexamethasone intravitreal implant for retinal vein occlusion in the USA
por: Nghiem-Buffet, S, et al.
Publicado: (2017)

Efficacy of intravitreal ranibizumab combined with Ahmed glaucoma valve implantation for the treatment of neovascular glaucoma
por: Tang, Min, et al.
Publicado: (2016)

Responsiveness of eyes with polypoidal choroidal vasculopathy with choroidal hyperpermeability to intravitreal ranibizumab
por: Sonoda, Shozo, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_svt63h16l8lghm830uitcql4l5